Mendus

Quick facts

Phase 2 pipeline

• DCP-001 · Diabetes
  DCP-001 is a small molecule that targets the SGLT2 receptor.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Mendus portfolio CI brief
• Mendus pipeline updates RSS